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Purpose
To optimise the cost effectiveness of MACI, we have
developed a new intraoperative procedure (Ortho-ACI™)
of seeding chondrocytes onto the type I/III collagen scaf-
fold and reported on laboratory validation of the proce-
dure and clinical outcomes of Ortho-ACI™.
Methods and Materials
We tested cell retention on the scaffold by confocal
microscopy at 7, 15, 20, 40, 60, 90 and 120 minutes after
seeding, and the molecular profile (collagen II, aggrecan,
Sox9, HAPLN1) of chondrocytes seeded at 20 minutes
and 4 days (preoperative seeding method). Fifteen Ortho-
ACI™ patients with 25 cartilage defects were assessed by
arthroscopic or magnetic resonance imaging (MRI). Graft
repair was graded as excellent, good, poor or no infill.
Associations between repair outcome and case variables
were also investigated.
Results
Intraoperative seeded scaffolds had 79% cell retention at
7 minutes, 97% at 20 minutes and 99% at 90 minutes.
Molecular profiling at 20 minutes was more consistent
with primary chondrocytes than at 4 days. Most grafts
were to patella defects (36%), then medial femoral con-
dyle and trochlea (total 80%). Good or excellent
MRI outcomes were noted in 100% of grafts at a mean
25 months follow-up (n=5). Good or excellent second
look arthroscopy outcomes were noted in 83% of cases at a
mean 17 months follow-up (n=24). Graft-related complica-
tions were noted in 29% (7/24) of cases, with all presenting
as graft edge tissue overgrowth. Six of these 7 overgrowth
cases were graded as excellent arthroscopic repair.
Conclusion
The Ortho-ACI™ procedure, utilizing chondrocytes seed-
ing onto collagen scaffold in the theatre, retains viable cells
with suitable molecular profile for implantation. With a lim-
ited number of cases, Ortho-ACI™ demonstrated good to
excellent MRI and arthroscopic repair outcomes. Although
more long-term data is needed, the findings of this study
suggest that the Ortho-ACI™ procedure is safe, clinically
effective and represents an innovative and cost-effective
ACI procedure.
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